HEALTHCARE TRIANGLE INC (HCTI) Stock Earnings & Estimates
USA - NASDAQ:HCTI - US42227W3060 - Common Stock
1.83 USD
-0.07 (-3.68%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 45.89M 30.11% | 33.203M -27.65% | 11.696M -64.77% | 19.601M 67.59% | 28.453M 45.16% | 34.143M 20.00% | 40.971M 20.00% | |
| EBITDA YoY % growth | -7.05M -78.93% | -4.419M 37.32% | -3.862M 12.60% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -10.42M -94.40% | -5.985M 42.56% | -4.751M 20.62% | N/A | N/A | N/A | 3.286M | |
| Operating Margin | -22.71% | -18.03% | -40.62% | N/A | N/A | N/A | 8.02% | |
| EPS YoY % growth | N/A | N/A 40.00% | N/A 25.00% | -1.40 -1,422.22% | -0.26 81.75% | 0.01 104.00% | 0.43 4,100.00% |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -0.22 | -0.14 |
| Revenue Q2Q % growth | 5.081M 110.57% | 7.113M 224.79% |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -1.254M -7.42% | -967.98K -94.37% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 50.00% | -0.02 | % | |
| Q3 2023 Q2Q % growth | 95.63% | -0.03 | % | |
| Q2 2023 Q2Q % growth | 69.40% | -0.03 | % | |
| Q1 2023 Q2Q % growth | 91.84% | -0.04 | % | |
| Q4 2022 Q2Q % growth | 66.00% | -0.04 | % | |
| Q3 2022 Q2Q % growth | -0.70 | -0.41 | -0.29 | -71.57% |
| Q2 2022 Q2Q % growth | -0.10 | -0.51 | 0.41 | 80.39% |
| Q1 2022 Q2Q % growth | -0.50 | -0.51 | 0.01 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 3.558M 19.24% | % | ||
| Q1 2025 Q2Q % growth | 3.704M -9.86% | % | ||
| Q4 2024 Q2Q % growth | 2.19M -68.98% | % | ||
| Q3 2024 Q2Q % growth | 2.413M -68.98% | % | ||
| Q2 2024 Q2Q % growth | 2.984M -65.02% | % | ||
| Q1 2024 Q2Q % growth | 4.109M -58.24% | % | ||
| Q4 2023 Q2Q % growth | 7.06M -37.47% | 15.096M | -8.036M | -53.23% |
| Q3 2023 Q2Q % growth | 7.78M -34.90% | 14.79M | -7.01M | -47.40% |
| Q2 2023 Q2Q % growth | 8.53M -26.40% | 13.872M | -5.342M | -38.51% |
| Q1 2023 Q2Q % growth | 9.84M -11.03% | 13.158M | -3.318M | -25.22% |
| Q4 2022 Q2Q % growth | 11.29M 22.85% | 12.648M | -1.358M | -10.74% |
| Q3 2022 Q2Q % growth | 11.95M 47.90% | 12.852M | -902K | -7.02% |
| Q2 2022 Q2Q % growth | 11.59M 15.32% | 11.934M | -344K | -2.88% |
| Q1 2022 Q2Q % growth | 11.06M 39.12% | 10.608M | 452K | 4.26% |
| Q4 2021 Q2Q % growth | 9.19M 2.22% | % | ||
| Q3 2021 Q2Q % growth | 8.08M 9.78% | % | ||
| Q2 2021 Q2Q % growth | 10.05M 32.94% | % | ||
| Q1 2021 Q2Q % growth | 7.95M 7.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |